Resultados de la búsqueda 431-440 of 1244 for total t4
A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.
... total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
The purpose of this study is to systematically and prospectively record accurate and complete data regarding the clinical presentation, treatment, and ...
The primary objective of the study is to evaluate the Overall Survival (OS). Numeración de páginas Estudios clínicos. AnteriorPágina anterior · Ir a página 22 ...
The primary objective of the study is to evaluate the Overall Survival (OS). A Feasibility Study To Evaluate The Safety Of The TheraSphere Glioblastoma (GBM) ...
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...
Subjects in the Biobank will provide samples of excess breast tissue, complete ... overall survival, time to progression, stage at progression, secondary ...
Complete response is at 3 or 6 months defined as absence of any UTUC in the renal pelvis. Undiagnosed Tumor/Undifferentiated Mass Registry. Rochester, Minn ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?